Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.

<h4>Objectives</h4>The aim of this study was to evaluate the discriminant capability of the patient acceptable symptom state (PASS) according to disease activity, in a cohort of Italian patients affected by systemic Lupus erythematosus (SLE).<h4>Methods</h4>Consecutive SLE pa...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fabrizio Conti, Fulvia Ceccarelli, Laura Massaro, Viviana A Pacucci, Francesca Miranda, Simona Truglia, Enrica Cipriano, Francesco Martinelli, Ilaria Leccese, Francesca Romana Spinelli, Cristiano Alessandri, Carlo Perricone, Guido Valesini
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2f76570f46e7467cbd1e3f40006fde2f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2f76570f46e7467cbd1e3f40006fde2f
record_format dspace
spelling oai:doaj.org-article:2f76570f46e7467cbd1e3f40006fde2f2021-11-18T08:56:17ZEvaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.1932-620310.1371/journal.pone.0073517https://doaj.org/article/2f76570f46e7467cbd1e3f40006fde2f2013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24039971/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>The aim of this study was to evaluate the discriminant capability of the patient acceptable symptom state (PASS) according to disease activity, in a cohort of Italian patients affected by systemic Lupus erythematosus (SLE).<h4>Methods</h4>Consecutive SLE patients were enrolled. At each visit, the patients underwent a complete physical examination and the clinical/laboratory data were collected in a standardized, computerized, and electronically-filled form. The evaluation of serum complement C3 and C4 levels and determination of autoantibodies was obtained. Disease activity was assessed with the SLEDAI-2K and ECLAM, while chronic damage was measured with the SLICC. Finally, PASS was assessed in all patients by asking to answer yes or no to a single question.<h4>Results</h4>One hundred sixty-five patients were enrolled (M/F 12/153; mean age 40.4±11.8 years, mean disease duration 109.1±96.2 months). No patients refused to answer, suggesting the acceptability of PASS. A total of 80% of patients rated their state as acceptable. The patients with an acceptable status had significantly lower mean SLEDAI-2K and ECLAM scores than the others [1.8±2.7 versus 3.4±2.3(P=0.004); 0.7±0.9 versus 1.4±1.1(P=0.0027)]. No significant differences were observed when considering chronic damage, evaluated with SLICC.<h4>Conclusions</h4>In the clinical practice, SLE patients assessment performed by using complex disease activity indices such as SLEDAI-2K and ECLAM, could be time consuming. In our study, for the first time, we used PASS, a quick and easily comprehensible tool, to evaluate the patients' status, this single question seems to be able to discriminate patients with different disease activity, especially when this is determined by musculoskeletal involvement.Fabrizio ContiFulvia CeccarelliLaura MassaroViviana A PacucciFrancesca MirandaSimona TrugliaEnrica CiprianoFrancesco MartinelliIlaria LecceseFrancesca Romana SpinelliCristiano AlessandriCarlo PerriconeGuido ValesiniPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e73517 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fabrizio Conti
Fulvia Ceccarelli
Laura Massaro
Viviana A Pacucci
Francesca Miranda
Simona Truglia
Enrica Cipriano
Francesco Martinelli
Ilaria Leccese
Francesca Romana Spinelli
Cristiano Alessandri
Carlo Perricone
Guido Valesini
Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
description <h4>Objectives</h4>The aim of this study was to evaluate the discriminant capability of the patient acceptable symptom state (PASS) according to disease activity, in a cohort of Italian patients affected by systemic Lupus erythematosus (SLE).<h4>Methods</h4>Consecutive SLE patients were enrolled. At each visit, the patients underwent a complete physical examination and the clinical/laboratory data were collected in a standardized, computerized, and electronically-filled form. The evaluation of serum complement C3 and C4 levels and determination of autoantibodies was obtained. Disease activity was assessed with the SLEDAI-2K and ECLAM, while chronic damage was measured with the SLICC. Finally, PASS was assessed in all patients by asking to answer yes or no to a single question.<h4>Results</h4>One hundred sixty-five patients were enrolled (M/F 12/153; mean age 40.4±11.8 years, mean disease duration 109.1±96.2 months). No patients refused to answer, suggesting the acceptability of PASS. A total of 80% of patients rated their state as acceptable. The patients with an acceptable status had significantly lower mean SLEDAI-2K and ECLAM scores than the others [1.8±2.7 versus 3.4±2.3(P=0.004); 0.7±0.9 versus 1.4±1.1(P=0.0027)]. No significant differences were observed when considering chronic damage, evaluated with SLICC.<h4>Conclusions</h4>In the clinical practice, SLE patients assessment performed by using complex disease activity indices such as SLEDAI-2K and ECLAM, could be time consuming. In our study, for the first time, we used PASS, a quick and easily comprehensible tool, to evaluate the patients' status, this single question seems to be able to discriminate patients with different disease activity, especially when this is determined by musculoskeletal involvement.
format article
author Fabrizio Conti
Fulvia Ceccarelli
Laura Massaro
Viviana A Pacucci
Francesca Miranda
Simona Truglia
Enrica Cipriano
Francesco Martinelli
Ilaria Leccese
Francesca Romana Spinelli
Cristiano Alessandri
Carlo Perricone
Guido Valesini
author_facet Fabrizio Conti
Fulvia Ceccarelli
Laura Massaro
Viviana A Pacucci
Francesca Miranda
Simona Truglia
Enrica Cipriano
Francesco Martinelli
Ilaria Leccese
Francesca Romana Spinelli
Cristiano Alessandri
Carlo Perricone
Guido Valesini
author_sort Fabrizio Conti
title Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
title_short Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
title_full Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
title_fullStr Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
title_full_unstemmed Evaluation of the patient acceptable symptom state (PASS) in Italian patients affected by systemic lupus erythematosus: association with disease activity indices.
title_sort evaluation of the patient acceptable symptom state (pass) in italian patients affected by systemic lupus erythematosus: association with disease activity indices.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/2f76570f46e7467cbd1e3f40006fde2f
work_keys_str_mv AT fabrizioconti evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT fulviaceccarelli evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT lauramassaro evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT vivianaapacucci evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT francescamiranda evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT simonatruglia evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT enricacipriano evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT francescomartinelli evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT ilarialeccese evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT francescaromanaspinelli evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT cristianoalessandri evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT carloperricone evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
AT guidovalesini evaluationofthepatientacceptablesymptomstatepassinitalianpatientsaffectedbysystemiclupuserythematosusassociationwithdiseaseactivityindices
_version_ 1718421132449677312